161 related articles for article (PubMed ID: 36125826)
1. Diverse Synthetic Approaches and Biological Activities of Lucrative Pyrimidine- Triazine Hybrid Derivatives: A Review.
Asgaonkar K; Patil S; Pradhan K; Tanksali S; Jain J
Curr Org Synth; 2023; 20(7):734-757. PubMed ID: 36125826
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Docking Study of Pyrimidine-Triazine Hybrids for GABA Estimation in Animal Epilepsy Models.
Sahu M; Siddiqui N; Naim MJ; Alam O; Yar MS; Sharma V; Wakode S
Arch Pharm (Weinheim); 2017 Sep; 350(9):. PubMed ID: 28758238
[TBL] [Abstract][Full Text] [Related]
3. Triazine as a promising scaffold for its versatile biological behavior.
Singla P; Luxami V; Paul K
Eur J Med Chem; 2015 Sep; 102():39-57. PubMed ID: 26241876
[TBL] [Abstract][Full Text] [Related]
4. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.
Jameel E; Meena P; Maqbool M; Kumar J; Ahmed W; Mumtazuddin S; Tiwari M; Hoda N; Jayaram B
Eur J Med Chem; 2017 Aug; 136():36-51. PubMed ID: 28478343
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
[TBL] [Abstract][Full Text] [Related]
6. Heterocyclic Compounds Bearing Triazine Scaffold and Their Biological Significance: A Review.
Verma T; Sinha M; Bansal N
Anticancer Agents Med Chem; 2020; 20(1):4-28. PubMed ID: 31746306
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, molecular docking and pharmacological evaluation of novel triazine-based triazole derivatives as potential anticonvulsant agents.
Alhamzani AG; Yousef TA; Abou-Krisha MM; Raghu MS; Yogesh Kumar K; Prashanth MK; Jeon BH
Bioorg Med Chem Lett; 2022 Dec; 77():129042. PubMed ID: 36332884
[TBL] [Abstract][Full Text] [Related]
8. Synthetic and pharmacological developments in the hybrid s-triazine moiety: A review.
Bareth D; Jain S; Kumawat J; Kishore D; Dwivedi J; Hashmi SZ
Bioorg Chem; 2024 Feb; 143():106971. PubMed ID: 38016395
[TBL] [Abstract][Full Text] [Related]
9. Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure-activity relationship and biological activity as potential antitumor and anticonvulsant agents.
Lamie PF; El-Kalaawy AM; Abdel Latif NS; Rashed LA; Philoppes JN
Eur J Med Chem; 2021 Mar; 214():113222. PubMed ID: 33545637
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of hydrazone incorporated 1,2,4-triazines as anticonvulsant agents.
Amir M; Ali I; Hassan MZ; Mulakayala N
Arch Pharm (Weinheim); 2014 Dec; 347(12):958-68. PubMed ID: 25251582
[TBL] [Abstract][Full Text] [Related]
11. Azole-Pyrimidine Hybrid Anticancer Agents: A Review of Molecular Structure, Structure Activity Relationship, and Molecular Docking.
Eze CC; Ezeokonkwo AM; Ugwu ID; Eze UF; Onyeyilim EL; Attah IS; Okonkwo IV
Anticancer Agents Med Chem; 2022 Aug; 22(16):2822-2851. PubMed ID: 35306990
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of benzimidazolyl-1,3,5-triazine and benzimidazolylpyrimidine derivatives.
Matsuno T; Karo M; Sasahara H; Watanabe T; Inaba M; Takahashi M; Yaguchi SI; Yoshioka K; Sakato M; Kawashima S
Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1778-81. PubMed ID: 11086914
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Biological Evaluation of 6-(2-Amino-substituted phenyl)-4-(substituted phenyl)-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Anticonvulsant Agents.
Khan AA; Siddiqui N; Akhtar MJ; Ali Z; Yar MS
Arch Pharm (Weinheim); 2016 Apr; 349(4):277-92. PubMed ID: 26996080
[TBL] [Abstract][Full Text] [Related]
14. Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition.
Ghanim AM; Rezq S; Ibrahim TS; Romero DG; Kothayer H
Eur J Med Chem; 2021 Jul; 219():113457. PubMed ID: 33892270
[TBL] [Abstract][Full Text] [Related]
15. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
[TBL] [Abstract][Full Text] [Related]
16. 1,3,5-Triazine-azole Hybrids and their Anticancer Activity.
Guo H; Diao QP
Curr Top Med Chem; 2020; 20(16):1481-1492. PubMed ID: 32156236
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological activities of some triazinopyrazolothieno pyrimidine derivatives.
Bahashwan SA
Acta Pharm; 2017 Sep; 67(3):407-414. PubMed ID: 28858840
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, docking simulation, biological evaluations and 3D-QSAR study of 5-Aryl-6-(4-methylsulfonyl)-3-(metylthio)-1,2,4-triazine as selective cyclooxygenase-2 inhibitors.
Irannejad H; Kebriaieezadeh A; Zarghi A; Montazer-Sadegh F; Shafiee A; Assadieskandar A; Amini M
Bioorg Med Chem; 2014 Jan; 22(2):865-73. PubMed ID: 24361187
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of thieno [2',3':4,5]pyrimido[1,2-b][1,2,4]triazines and thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines as anti-inflammatory and analgesic agents.
Ashour HM; Shaaban OG; Rizk OH; El-Ashmawy IM
Eur J Med Chem; 2013 Apr; 62():341-51. PubMed ID: 23376247
[TBL] [Abstract][Full Text] [Related]
20. 1,2,4-triazine analogs as novel class of therapeutic agents.
Kumar R; Sirohi TS; Singh H; Yadav R; Roy RK; Chaudhary A; Pandeya SN
Mini Rev Med Chem; 2014 Feb; 14(2):168-207. PubMed ID: 24479860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
